English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Type IV CRISPR RNA processing and effector complex formation in Aromatoleum aromaticum

MPS-Authors
/persons/resource/persons254588

Özcan,  Ahsen
Max Planck Research Group Prokaryotic small RNA Biology, Alumni, Max Planck Institute for Terrestrial Microbiology, Max Planck Society;

/persons/resource/persons254596

Pausch,  Patrick
Max Planck Research Group Prokaryotic small RNA Biology, Alumni, Max Planck Institute for Terrestrial Microbiology, Max Planck Society;

/persons/resource/persons225538

Linden,  Andreas
Research Group of Bioanalytical Mass Spectrometry, MPI for Biophysical Chemistry, Max Planck Society;

/persons/resource/persons213790

Wulf,  Alexander
Research Group of Bioanalytical Mass Spectrometry, MPI for Biophysical Chemistry, Max Planck Society;

/persons/resource/persons15947

Urlaub,  Henning
Research Group of Bioanalytical Mass Spectrometry, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons254626

Randau,  Lennart
Max Planck Research Group Prokaryotic small RNA Biology, Alumni, Max Planck Institute for Terrestrial Microbiology, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Özcan, A., Pausch, P., Linden, A., Wulf, A., Schuehle, K., Heider, J., et al. (2019). Type IV CRISPR RNA processing and effector complex formation in Aromatoleum aromaticum. NATURE MICROBIOLOGY, 4(1), 89-+. doi:10.1038/s41564-018-0274-8.


Cite as: https://hdl.handle.net/21.11116/0000-0008-BF62-3
Abstract
Type IV CRISPR-Cas modules belong to class 1 prokaryotic adaptive immune
systems, which are defined by the presence of multisubunit effector
complexes. They usually lack the known Cas proteins involved in
adaptation and target cleavage, and their function has not been
experimentally addressed. To investigate RNA and protein components of
this CRISPR-Cas type, we located a complete type IV cas gene locus and
an adjacent CRISPR array on a megaplasmid of Aromatoleum aromaticum
EbN1, which contains an additional type I-C system on its chromosome.
RNA sequencing analyses verified CRISPR RNA (crRNA) production and
maturation for both systems. Type IV crRNAs were shown to harbour
unusually short 7 nucleotide 5'-repeat tags and stable 3' hairpin
structures. A unique Cas6 variant (Csf5) was identified that generates
crRNAs that are specifically incorporated into type IV
CRISPR-ribonucleoprotein (crRNP) complexes. Structures of RNA-bound Csf5
were obtained. Recombinant production and purification of the type IV
Cas proteins, together with electron microscopy, revealed that Csf2 acts
as a helical backbone for type IV crRNPs that include Csf5, Csf3 and a
large subunit (Csf1). Mass spectrometry analyses identified
protein-protein and protein-RNA contact sites. These results highlight
evolutionary connections between type IV and type I CRISPR-Cas systems
and demonstrate that type IV CRISPR-Cas systems employ crRNA-guided
effector complexes.